北柴胡与南柴胡抗炎作用及GC-MS代谢组学鉴别比较
该研究比较了北柴胡(BCH)与南柴胡(NCH)超临界流体提取物(SFE)和加氢蒸馏提取物(HDE)对LPS诱导RAW264.7巨噬细胞炎症的抗炎作用,并用GC-MS代谢组学与深度化学计量学方法筛选化学标志物。结果显示SFE抗炎效力强于HDE,NCH抗炎作用高于BCH,并优化出含15个化学标志物的最小组合用于两种柴胡的物种鉴别。
要点
- SFE抗炎效力明显强于HDE,南柴胡抗炎作用高于北柴胡。
- GC-MS代谢组学结合化学计量学可优化出15个化学标志物用于鉴别。
- 该研究为北柴胡与南柴胡的质量控制方法改进提供潜在化学标志物。
核心结论
- 北柴胡与南柴胡在抗炎作用和化学成分上存在差异,南柴胡抗炎作用更强,基于GC-MS代谢组学优化的15个化学标志物组合可用于两物种鉴别。
研究设计与样本
- 研究采用体外LPS诱导RAW264.7巨噬细胞炎症模型评价北柴胡与南柴胡超临界流体提取物和加氢蒸馏提取物的抗炎作用。
- 同时采用GC-MS代谢组学与深度化学计量学方法对两种柴胡进行化学成分表征和物种鉴别分析。
主要发现
- 超临界流体提取物对LPS诱导RAW264.7巨噬细胞炎症的IC50:北柴胡6.39 ± 0.52 mg(herb)/mL,南柴胡1.32 ± 0.05 mg(herb)/mL。
- 加氢蒸馏提取物对LPS诱导RAW264.7巨噬细胞炎症的IC50:北柴胡203.90 ± 8.08 mg(herb)/mL,南柴胡32.32 ± 2.27 mg(herb)/mL。
- 南柴胡抗炎作用高于北柴胡,与其化学成分不同于北柴胡相关。
- 基于代谢组学和深度化学计量学方法,从已鉴定成分中优化出含15个化学标志物的最小组合,并成功用于北柴胡与南柴胡的物种鉴别。
临床怎么用
- 中药师与临床医生可关注北柴胡与南柴胡在抗炎相关应用中的潜在药效差异。
- 该研究提供的15个化学标志物组合可为北柴胡与南柴胡的质量控制方法改进提供参考。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Bupleuri Radix (BR) is a traditional Chinese medicine and widely used for cold and fever, influenza, inflammation, hepatitis and menstrual diseases. Two authentic medicinal plants of Bupleuri chinense DC. (Beichaihu, BCH) and B. scorzonerifolium Willd. (Nanchiahu, NCH) are recommended by the current Chinese Pharmacopoeia for BR. In the present study, the comparative investigations on the anti-inflammatory effects and gas chromatography-mass spectrometry (GC-MS)-based metabolomics for the species discrimination of BCH and NCH were conducted and reported. The in vitro evaluations indicated that the supercritical fluid extracts (SFEs) (IC50 of 6.39 ± 0.52 and 1.32 ± 0.05 mg (herb)/mL for BCH and NCH) were determined to be more potent than those of the hydro-distillation extracts (HDEs) (IC50 of 203.90 ± 8.08 and 32.32 ± 2.27 mg (herb)/mL for BCH and NCH) against LPS-induced inflammation in RAW264.7 macrophages. The higher anti-inflammatory effects of NCH were associated to its different chemical compositions to the BCH as characterized by the GC-MS analysis. Furthermore, based on the metabolomics and deep chemometric approaches, a minimum combination containing 15 chemical markers was optimized from the identified components and successfully applied for the species discrimination of BCH and NCH. This study not only helps to comparative understand BCH and NCH both in phytochemistry and pharmacology, but also provides the potential chemical markers for improvement of methods for the quality control of BCH and NCH.
引用
- Zhao M, Xiao L, Linghu KG, et al. Comprehensive comparison on the anti-inflammation and GC-MS-based metabolomics discrimination between Bupleuri chinense DC. and B. scorzonerifolium Willd. Front Pharmacol. 2022. PMID: 36188603. doi:10.3389/fphar.2022.1005011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。